Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

45 results about "Glutathione synthetase" patented technology

Glutathione synthetase (GSS) (EC 6.3.2.3) is the second enzyme in the glutathione (GSH) biosynthesis pathway. It catalyses the condensation of gamma-glutamylcysteine and glycine, to form glutathione. Glutathione synthetase is also a potent antioxidant. It is found in many species including bacteria, yeast, mammals, and plants.

Method for producing glutathione by use of metabolic engineering bacteria

The invention provides a glutathione synthetase-system recombinant plasmid as well as a construction method and application thereof, a recombinant strain for expressing glutathione synthetase systems as well as a construction method and application thereof, and a method for producing glutathione. The glutathione synthetase-system recombinant plasmid comprises a GSH1 sequence, a GSH1 sequence and a suitable vector fragment. The recombinant strain for glutathione synthetase systems is constructed by use of the glutathione synthetase-system recombinant plasmid. The method for producing glutathione comprises the step of fermenting the recombinant strain for glutathione synthetase systems. Glutathione-producing Pichia pastoris can be constructed by use of the coexpression plasmid provided by the invention; the obtained glutathione-producing Pichia pastoris is fermented and cultured; and the yield of glutathione in obtained fermentation broth is significantly higher than the current reported highest level of glutathione fermentation production. The invention has the advantages of improving the utilization rate of raw materials and reducing production cost and energy consumption, and can be used for industrial production.
Owner:SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI +1

Anticancer implantation agent

Disclosed is an anti-cancer implant which comprises anti-cancer active constituent and medicinal adjuvant, wherein the active anti-cancer constituents mainly include blood vessel inhibitor and anti-cancer medicament, the anti-cancer medicament is selected from glutathione synthetic enzyme inhibitor or nitrogen oxide synthetic enzyme inhibitor or their combination, The medicinal subsidiary materials mainly comprise bio-compactable and degradable macromolecular polymers, which can slowly release the anti-cancer medicament onto tumor partially during the degradation and absorption process, thus the whole body toxicity reaction is reduced appreciably , and the effective medicinal concentration can be sustained to the tumor partially. when locally dispensed on the tumor, the composition can lower down the whole body toxicity reaction of the anti-cancer medicament, selectively increase the tumor local medicinal concentration, and the treatment effect of the non-operative treatment methods such as chemotherapy, medicament and radiation can be improved.
Owner:孔庆忠

Bifunctional glutathione synthetase expression cassette derived from lactobacillus as well as construction and application thereof

The invention provides a bifunctional glutathione synthetase expression cassette derived from lactobacillus. The bifunctional glutathione synthetase expression cassette includes cloning a gshF gene derived from the lactobacillus. The invention further provides a preparation method of the bifunctional glutathione synthetase expression cassette derived from the lactobacillus. The preparation methodcomprises the following steps: designing a primer for amplifying the gshF gene by taking a lactobacillus genome as a template; performing enzyme digestion with Ndel and Xhol; connecting to a polyclonal site of an escherichia coli pET expression vector through DNA ligase in order to construct the expression cassette expressing the lactobacillus gshF. The invention further provides a lactobacillus-containing gshF expression cassette escherichia coli genetically engineered bacterium. The invention further provides application of the lactobacillus-containing gshF expression cassette escherichia coli genetically engineered bacterium to preparation of glutathione. After the bifunctional glutathione synthetase expression cassette is applied to GSH synthesis, the GSH yield is up to 103.1mu m, theescherichia coli GSH yield is increased by 11.5 times or more, and the GSH synthesis ability of the escherichia coli is significantly improved.
Owner:UNIV OF SHANGHAI FOR SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products